Wed, Jul 30, 2014, 4:54 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Seattle Genetics Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • blackmenrock Mar 12, 2010 4:47 PM Flag

    SGN-33 Trial Revisited

    I'm thinking there will be quite a lag between initial approval and front-line.

    Phase I front-line trial is slated to begin in May. Add to that time line phase II and III and we're looking out quite a few years.

    Then there's the propensity for large institutional shorting weeks after an FDA approval (happens in almost all cases).

    Still with the pipeline and collaboration $40 may be doable.

    Of course I hope YOU are right.

    Shorter term I Like JAZZ.

35.89+0.73(+2.08%)4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.